We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
73 hedge funds and large institutions have $493M invested in Atara Biotherapeutics in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 44 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
450% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 8
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
32% more capital invested
Capital invested by funds: $374M → $493M (+$119M)
4% more funds holding
Funds holding: 70 → 73 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
73
Holders Change
+3
Holders Change %
+4.29%
% of All Funds
1.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
44
Reduced
8
Closed
6
Calls
$9K
Puts
–
Net Calls
+$9K
Net Calls Change
+$5K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.8M |
| 2 |
SPC
Slate Path Capital
New York
|
+$8.06M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$7.74M |
| 4 |
BM
Bridger Management
New York
|
+$5.31M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.75M |
Top Sellers
| 1 |
VAM
Visium Asset Management
New York
|
-$11.5M |
| 2 |
ARTA
A.R.T. Advisors
New York
|
-$1.22M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$1.21M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.05M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$1.03M |
